A strategic scientific communications company with over 100+ years of combined life-sciences medical affairs and marketing experience

About Us

Traditionalists might call us a strategic scientific communications agency, and as a company with more than 100+ combined years of oncology-specific medical affairs and marketing experience, we’re okay with that. However, having come from the traditional corporate-owned med comm world, we like to celebrate the ways we’re different.

We have two sentences in our company policy manual:

1) Make smart choices

2) Be nice

As people, it’s how we live our lives and as a company, it’s how we serve our clients. It doesn’t need to be more complicated than that. Our goal is to stay small enough to stay completely focused on helping you solve your problems; no internal barriers.

Call us boutique if you’d like. We think of ourselves as more craft. Maybe even artisan.

Want to get to know us better? Meet the Team

Why “Triptych”?

Triptych means “three-layered” in Greek. More commonly known to describe a set of three pictures or panels — sometimes hinged or folded — that together make a larger work of art.

In healthcare, we see three layers:

  • Patients needing treatment

  • Healthcare providers to treat them

  • Medicines and devices used as treatments.

Making sure all the players are as educated as possible about the treatments is our way of helping to build the hinge

OR it’s TRIPTYCH because one of our founding partners, Shawn, loves triptych art, or because her favorite number is three, or because there are three founding partners…whichever works for you is good with us!

Core Services & Capabilities

  • Annual Scientific, Medical Education, Medical Affairs & Communication Planning

    Conference Coverage and Strategic Insights Reporting

    Conference Planning and Execution

    Clinical Landscape Assessments

    Advisory Boards/Roundtables

  • Disease State Education

    Medical Education

    Medical Affairs/MSL Clinical Presentations

    Scientific Platform/Messaging

    Case Studies

    Posters /Abstracts

    Symposia

    Digital Media (Web, video, apps, emails, etc.)

  • Comprehensive KOL Identification, Profiling, Engagement Planning

    Comprehensive KOL Engagement Planning

    KOL Engagement Activities (Live and Virtual formats)

    Steering Committee Management

    Investigator Events

  • Advocacy Development

    Community and Patient Events

    Patient Education

Key Therapeutic Areas of Expertise

  • Breast cancer

    Gastrointestinal cancer

    Genitourinary cancer (prostate & bladder)

    Glioblastomas

    Lung cancer

    Renal cell cancer

    Sarcomas

  • Pre-launch (Phase II-III)

    Traditional & accelerated launches

    New indications

    Evolving clinical data

  • Acute myeloid leukemia (AML)

    Chronic myelogenous leukemia (CML)

    Multiple myeloma (MM)

    Myelodysplastic syndromes (MDS)

    Non-Hodgkin’s and Hodgkin’s lymphoma (NHL/HL)

    Peripheal T-cell lymphoma (PTCL)

  • US & global

    Large & small markets

    Novel technology/MOA

    Diagnostics

    FDA Interactions